THE ASPIRING MEDIC'S SUPPORT CIC

Company limited by guarantee

Company Registration Number:
11681631 (England and Wales)

Unaudited statutory accounts for the year ended 30 November 2025

Period of accounts

Start date: 1 December 2024

End date: 30 November 2025

THE ASPIRING MEDIC'S SUPPORT CIC

Contents of the Financial Statements

for the Period Ended 30 November 2025

Directors report
Profit and loss
Balance sheet
Additional notes
Community Interest Report

THE ASPIRING MEDIC'S SUPPORT CIC

Directors' report period ended 30 November 2025

The directors present their report with the financial statements of the company for the period ended 30 November 2025

Principal activities of the company

Principal Activities of the Company The Aspiring Medic's Support (TAMS) C.I.C. Company Number: 11681631 Reporting Period: 1 December 2024 – 30 November 2025 The Aspiring Medic's Support (TAMS) is a Community Interest Company established to advance education and widen participation in medicine for aspiring and current medical students from socioeconomically disadvantaged and widening participation (WP) backgrounds across the United Kingdom. Our mission is to ensure that students from widening participation backgrounds have equitable opportunities, choices, and outcomes throughout their journey into and through medical education. During the reporting period, the Company continued to deliver activities that furthered this mission through educational programmes, national events, digital resources, and stakeholder engagement. TAMS Scholars Programme The Company continued to deliver the TAMS Scholars Programme, providing structured personal and professional development opportunities for aspiring and current medical students from widening participation backgrounds. Participants benefited from mentoring, educational workshops, careers advice, and networking opportunities designed to improve access to medical careers and support progression through medical school. ThriveInMed Medical Students Conference During the year, the Company successfully delivered the ThriveInMed Medical Students Conference 2025 at the Royal College of Surgeons of England. The conference brought together medical students from across the United Kingdom, with a particular focus on supporting students from widening participation and working-class backgrounds. The event provided keynote lectures, panel discussions, workshops, networking opportunities, and career development sessions centred around the theme "More Than a Medic: Careers, Identity and Impact." The conference was delivered in collaboration with a number of respected organisations and professionals, helping students explore sustainable careers in medicine while building professional networks and confidence. Digital Engagement Throughout the reporting period, the Company continued to expand its digital presence through the ThriveInMed community, sharing educational resources, careers guidance, and widening participation content with students across the UK. These online activities enabled the Company to extend its reach beyond geographical boundaries and provide accessible support to a wider audience. Stakeholder Engagement The Company continued to work collaboratively with universities, healthcare professionals, charities, and national organisations committed to widening participation in medicine. Partnerships with organisations including the Royal College of Surgeons of England, the General Medical Council, the Medical Defence Union, Healthcare Leadership Academy, More Than Medics, and other widening participation organisations strengthened the quality and reach of the Company's activities. Public Benefit All activities undertaken during the reporting period were delivered in furtherance of the Company's community interest objectives. Through educational programmes, conferences, mentoring, freely accessible digital resources, and strategic partnerships, TAMS continued to work towards reducing barriers to medical education and supporting students from underrepresented backgrounds to realise their potential. The Directors believe that the Company's activities have continued to deliver a meaningful public benefit by improving access to educational opportunities, supporting career development, and promoting greater equity within medical education.

Political and charitable donations

No political or charitable donations



Directors

The director shown below has held office during the whole of the period from
1 December 2024 to 30 November 2025

Jacob Oguntimehin


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
30 July 2026

And signed on behalf of the board by:
Name: Jacob Oguntimehin
Status: Director

THE ASPIRING MEDIC'S SUPPORT CIC

Profit And Loss Account

for the Period Ended 30 November 2025

2025 2024


£

£
Turnover: 3,504 3,910
Gross profit(or loss): 3,504 3,910
Operating profit(or loss): 3,504 3,910
Profit(or loss) before tax: 3,504 3,910
Profit(or loss) for the financial year: 3,504 3,910

THE ASPIRING MEDIC'S SUPPORT CIC

Balance sheet

As at 30 November 2025

Notes 2025 2024


£

£
Current assets
Cash at bank and in hand: 561 3,908
Total current assets: 561 3,908
Net current assets (liabilities): 561 3,908
Total assets less current liabilities: 561 3,908
Total net assets (liabilities): 561 3,908
Members' funds
Profit and loss account: 561 3,908
Total members' funds: 561 3,908

The notes form part of these financial statements

THE ASPIRING MEDIC'S SUPPORT CIC

Balance sheet statements

For the year ending 30 November 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 30 July 2026
and signed on behalf of the board by:

Name: Jacob Oguntimehin
Status: Director

The notes form part of these financial statements

THE ASPIRING MEDIC'S SUPPORT CIC

Notes to the Financial Statements

for the Period Ended 30 November 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

THE ASPIRING MEDIC'S SUPPORT CIC

Notes to the Financial Statements

for the Period Ended 30 November 2025

  • 2. Employees

    2025 2024
    Average number of employees during the period 1 1

COMMUNITY INTEREST ANNUAL REPORT

THE ASPIRING MEDIC'S SUPPORT CIC

Company Number: 11681631 (England and Wales)

Year Ending: 30 November 2025

Company activities and impact

Principal Activities of the Company The Aspiring Medic's Support (TAMS) C.I.C. Company Number: 11681631 Reporting Period: 1 December 2024 – 30 November 2025 The Aspiring Medic's Support (TAMS) is a Community Interest Company established to advance education and widen participation in medicine for aspiring and current medical students from socioeconomically disadvantaged and widening participation (WP) backgrounds across the United Kingdom. Our mission is to ensure that students from widening participation backgrounds have equitable opportunities, choices, and outcomes throughout their journey into and through medical education. During the reporting period, the Company continued to deliver activities that furthered this mission through educational programmes, national events, digital resources, and stakeholder engagement. TAMS Scholars Programme The Company continued to deliver the TAMS Scholars Programme, providing structured personal and professional development opportunities for aspiring and current medical students from widening participation backgrounds. Participants benefited from mentoring, educational workshops, careers advice, and networking opportunities designed to improve access to medical careers and support progression through medical school. ThriveInMed Medical Students Conference During the year, the Company successfully delivered the ThriveInMed Medical Students Conference 2025 at the Royal College of Surgeons of England. The conference brought together medical students from across the United Kingdom, with a particular focus on supporting students from widening participation and working-class backgrounds. The event provided keynote lectures, panel discussions, workshops, networking opportunities, and career development sessions centred around the theme "More Than a Medic: Careers, Identity and Impact." The conference was delivered in collaboration with a number of respected organisations and professionals, helping students explore sustainable careers in medicine while building professional networks and confidence. Digital Engagement Throughout the reporting period, the Company continued to expand its digital presence through the ThriveInMed community, sharing educational resources, careers guidance, and widening participation content with students across the UK. These online activities enabled the Company to extend its reach beyond geographical boundaries and provide accessible support to a wider audience. Stakeholder Engagement The Company continued to work collaboratively with universities, healthcare professionals, charities, and national organisations committed to widening participation in medicine. Partnerships with organisations including the Royal College of Surgeons of England, the General Medical Council, the Medical Defence Union, Healthcare Leadership Academy, More Than Medics, and other widening participation organisations strengthened the quality and reach of the Company's activities. Public Benefit All activities undertaken during the reporting period were delivered in furtherance of the Company's community interest objectives. Through educational programmes, conferences, mentoring, freely accessible digital resources, and strategic partnerships, TAMS continued to work towards reducing barriers to medical education and supporting students from underrepresented backgrounds to realise their potential. The Directors believe that the Company's activities have continued to deliver a meaningful public benefit by improving access to educational opportunities, supporting career development, and promoting greater equity within medical education.

Consultation with stakeholders

Consultation with Stakeholders The Company actively consults with its stakeholders to ensure its activities continue to meet the needs of aspiring and current medical students from widening participation backgrounds. Throughout the reporting period, feedback was gathered from participants attending the TAMS Scholars Programme, ThriveInMed community members, conference delegates, volunteers, mentors, and partner organisations through surveys, informal discussions, and ongoing engagement. Insights from students directly informed the development of the Thrive Guide, which was created in response to commonly identified challenges relating to the hidden curriculum of medicine, research opportunities, career planning, finances, and wellbeing. Feedback from stakeholders also shaped the content of the ThriveInMed Medical Students Conference 2026. Students expressed a desire for greater exposure to sustainable and varied careers in medicine, leading to the conference theme "More Than a Medic: Careers, Identity and Impact." The programme was designed to include keynote speakers, interactive workshops, and panel discussions focused on career sustainability, portfolio careers, leadership, and professional identity. The Company also maintained regular dialogue with partner organisations, including the Royal College of Surgeons of England, the General Medical Council, More Than Medics, the Medical Defence Union, Healthcare Leadership Academy, and other widening participation organisations. Their advice and collaboration helped strengthen the quality, relevance, and reach of the Company's activities. The Directors remain committed to ensuring that the views of beneficiaries and stakeholders continue to shape the future direction of the Company and inform its public benefit activities.

Directors' remuneration

No remuneration was received

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
30 July 2026

And signed on behalf of the board by:
Name: Jacob Oguntimehin
Status: Director